Strides Pharma Science Limited Share Price & Analysis
₹1,051.3▼ -0.77%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹1,051.3
-0.77%
Open
₹—
High
₹1,063.8
Low
₹1,039.9
Close
₹1,051.3
52W High
₹1,231
52W Low
₹769
Volume
88K
Lot Size
1
Sector
Healthcare
Market Cap
₹10K Cr
Face Value
₹10
Mid Cap
Price Chart
Fundamentals
P/E
17.1
Sector P/E
54.4
P/B
3.59
EPS
₹60.39
ROE
20.4%
ROCE
18.6%
D/E Ratio
0.56
Div Yield
0.37%
Book Value
₹337
+
Strengths
- ✓Excellent return on equity (ROE 20.4%)
- ✓Efficient capital deployment (ROCE 18.6%)
- ✓Attractively valued vs sector (P/E 17.1x vs industry 54.4x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
STAR · as of Mar 2026
Promoters28.30%▲1.48
FII28.32%▼0.16
DII13.72%▼3.20
Public29.65%▲1.87
Govt0.01%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 27.39% | 25.88% | 25.86% | 25.84% | 26.82% | 28.30% |
| FII | 19.45% | 24.57% | 26.71% | 30.08% | 28.48% | 28.32% |
| DII | 19.02% | 17.66% | 18.17% | 18.24% | 16.92% | 13.72% |
| Public | 33.75% | 31.52% | 28.87% | 25.83% | 27.78% | 29.65% |
| Govt | 0.39% | 0.39% | 0.39% | 0.01% | 0.01% | 0.01% |
Corporate Events
Dividend - Rs 5 Per Share
Dividend30 Jul 2026
Dividend - Rs 4 Per Share
Dividend21 Jul 2025
Demerger
Event5 Dec 2024
Dividend - Rs 2.50 Per Share
Dividend8 Sept 2024
Dividend - Rs 1.50 Per Share
Dividend3 Aug 2023
Latest News
All news →Disney injects ₹123 crore into JioStar India
*Disney injects ₹123 crore into JioStar India* to strengthen its post-merger operations. This follows the recent integration of Disney’s Indian media assets with Reliance’s JioStar. The move signals continued confidence in the combined entity’s growth strategy. JioStar operates under Reliance Industries, which owns the controlling stake. 📊 *STOCKS:* RELIANCE | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #JioStar
Storyboard182 Jul
Disney invests ₹123 Cr in JioStar India joint venture
Disney has infused ₹**123 Cr** into its Indian joint venture, JioStar, boosting its media and entertainment footprint. The move strengthens the partnership between Disney and Reliance Industries in India’s competitive OTT and TV segment. The capital injection reflects continued confidence in India’s media growth story. 📊 *STOCKS:* | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #JointVenture
outlookbusiness.com1 Jul
JioStar eases pressure on Disney with improved India performance
*JioStar eases pressure on Disney with improved India performance.* The integration of JioCinema and Star India is showing positive traction, reducing losses in Disney’s Indian operations. Revenue from Indian streaming now contributes **$200 million annually**, with subscriber growth up **15% YoY**. This turnaround lessens the drag on Disney’s global earnings. 📊 *STOCKS:* TWDC | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #Disney
PitchOnnet25 May
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.3K Cr ▲10.7% | ₹1.2K Cr ▼2.1% | ₹1.2K Cr ▲9.0% | ₹1.1K Cr ▼5.9% | ₹1.2K Cr ▲3.1% | ₹1.2K Cr ▼1.1% | ₹1.2K Cr ▲10.7% | ₹1.1K Cr |
| Op. Profit | ₹240 Cr ▲1.7% | ₹236 Cr ▲2.2% | ₹231 Cr ▲6.0% | ₹218 Cr ▲0.0% | ₹218 Cr ▲3.8% | ₹210 Cr ▲14.1% | ₹184 Cr ▼2.1% | ₹188 Cr |
| OPM | 18.0% ▼10.0% | 20.0% ▲5.3% | 19.0% ▲0.0% | 19.0% ▲5.6% | 18.0% ▲0.0% | 18.0% ▲12.5% | 16.0% ▼11.1% | 18.0% |
| Net Profit | ₹129 Cr ▼38.0% | ₹208 Cr ▲57.6% | ₹132 Cr ▲24.5% | ₹106 Cr ▲23.3% | ₹86 Cr ▼4.4% | ₹90 Cr ▲25.0% | ₹72 Cr ▼97.9% | ₹3.4K Cr |
| EPS (₹) | 13.77 ▼37.2% | 21.93 ▲58.5% | 13.84 ▲28.1% | 10.8 ▲21.2% | 8.91 ▼6.6% | 9.54 ▲22.2% | 7.81 ▼97.9% | 364.69 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹4.9K Cr ▲6.4% | ₹4.6K Cr ▲17.4% | ₹3.9K Cr ▲5.5% | ₹3.7K Cr ▲20.1% | ₹3.1K Cr ▼7.4% | ₹3.3K Cr ▲20.5% | ₹2.8K Cr ▲26.4% | ₹2.2K Cr ▼23.4% | ₹2.8K Cr ▲3.3% | ₹2.8K Cr |
| Expenses | ₹3.9K Cr ▲4.5% | ₹3.8K Cr ▲11.9% | ₹3.4K Cr ▼5.1% | ₹3.5K Cr ▲10.7% | ₹3.2K Cr ▲15.2% | ₹2.8K Cr ▲18.9% | ₹2.3K Cr ▲18.0% | ₹2.0K Cr ▼19.0% | ₹2.4K Cr ▲9.9% | ₹2.2K Cr |
| Op. Profit | ₹925 Cr ▲15.2% | ₹803 Cr ▲52.1% | ₹528 Cr ▲264.1% | ₹145 Cr ▲210.7% | ₹-131 Cr ▼124.4% | ₹537 Cr ▲29.7% | ₹414 Cr ▲110.2% | ₹197 Cr ▼50.5% | ₹398 Cr ▼24.5% | ₹527 Cr |
| OPM | 19.0% ▲5.6% | 18.0% ▲28.6% | 14.0% ▲250.0% | 4.0% ▲200.0% | -4.0% ▼125.0% | 16.0% ▲6.7% | 15.0% ▲66.7% | 9.0% ▼35.7% | 14.0% ▼26.3% | 19.0% |
| Other Income | ₹124 Cr ▼96.3% | ₹3.3K Cr ▲3413.0% | ₹-100 Cr ▼208.7% | ₹92 Cr ▲182.1% | ₹-112 Cr ▼202.8% | ₹109 Cr ▲353.5% | ₹-43 Cr ▼114.2% | ₹303 Cr ▼52.9% | ₹643 Cr ▲121.0% | ₹291 Cr |
| Interest | ₹179 Cr ▼28.1% | ₹249 Cr ▼11.1% | ₹280 Cr ▲7.3% | ₹261 Cr ▲47.5% | ₹177 Cr ▲18.0% | ₹150 Cr ▼3.8% | ₹156 Cr ▲97.5% | ₹79 Cr ▼59.7% | ₹196 Cr ▲7.1% | ₹183 Cr |
| Depreciation | ₹202 Cr ▲5.2% | ₹192 Cr ▼10.3% | ₹214 Cr ▼11.9% | ₹243 Cr ▲4.3% | ₹233 Cr ▲13.1% | ₹206 Cr ▲18.4% | ₹174 Cr ▲48.7% | ₹117 Cr ▼24.0% | ₹154 Cr ▲22.2% | ₹126 Cr |
| PBT | ₹669 Cr ▼81.8% | ₹3.7K Cr ▲5753.8% | ₹-65 Cr ▲75.7% | ₹-268 Cr ▲59.0% | ₹-653 Cr ▼326.0% | ₹289 Cr ▲588.1% | ₹42 Cr ▼86.1% | ₹303 Cr ▼56.1% | ₹690 Cr ▲35.6% | ₹509 Cr |
| Tax % | 14.0% ▲600.0% | 2.0% ▼95.6% | 45.0% ▲314.3% | -21.0% ▲22.2% | -27.0% ▼345.5% | 11.0% ▼59.3% | 27.0% ▲400.0% | -9.0% ▼1000.0% | 1.0% ▼91.7% | 12.0% |
| Net Profit | ₹575 Cr ▼84.0% | ₹3.6K Cr ▲3927.7% | ₹-94 Cr ▲55.7% | ₹-212 Cr ▲55.3% | ₹-474 Cr ▼283.7% | ₹258 Cr ▲732.3% | ₹31 Cr ▼90.6% | ₹330 Cr ▼51.8% | ₹684 Cr ▲53.4% | ₹446 Cr |
| EPS (₹) | 60.34 ▼84.5% | 389.75 ▲5174.9% | -7.68 ▲65.8% | -22.44 ▲56.2% | -51.25 ▼271.2% | 29.93 ▲637.2% | 4.06 ▼88.8% | 36.27 ▼51.2% | 74.25 ▲66.1% | 44.71 |
| Div Payout | 8.0% ▲700.0% | 1.0% ▲103.0% | -33.0% ▼371.4% | -7.0% | 0.0% ▼100.0% | 8.0% ▼97.7% | 345.0% ▲4212.5% | 8.0% ▲166.7% | 3.0% ▼70.0% | 10.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹92 Cr ▲0.0% | ₹92 Cr ▲0.0% | ₹92 Cr ▲2.2% | ₹90 Cr ▲0.0% | ₹90 Cr ▲0.0% | ₹90 Cr ▲0.0% | ₹90 Cr ▲0.0% | ₹90 Cr ▲0.0% | ₹90 Cr ▲1.1% | ₹89 Cr |
| Reserves | ₹3.0K Cr ▲22.6% | ₹2.5K Cr ▲20.9% | ₹2.0K Cr ▼4.1% | ₹2.1K Cr ▼6.5% | ₹2.3K Cr ▼15.6% | ₹2.7K Cr ▲10.2% | ₹2.4K Cr ▼4.7% | ₹2.6K Cr ▲7.8% | ₹2.4K Cr ▼10.7% | ₹2.7K Cr |
| Borrowings | ₹1.8K Cr ▼6.5% | ₹1.9K Cr ▼25.3% | ₹2.5K Cr ▼16.9% | ₹3.0K Cr ▲0.2% | ₹3.0K Cr ▲28.8% | ₹2.3K Cr ▲5.1% | ₹2.2K Cr ▼30.6% | ₹3.2K Cr ▲27.8% | ₹2.5K Cr ▼31.9% | ₹3.7K Cr |
| Other Liabilities | ₹2.1K Cr ▲37.7% | ₹1.5K Cr ▲29.5% | ₹1.2K Cr ▼14.4% | ₹1.4K Cr ▼13.1% | ₹1.6K Cr ▼15.6% | ₹1.8K Cr ▲34.7% | ₹1.4K Cr ▼29.3% | ₹1.9K Cr ▲21.0% | ₹1.6K Cr ▲0.2% | ₹1.6K Cr |
| Total Liabilities | ₹6.9K Cr ▲16.8% | ₹5.9K Cr ▲2.2% | ₹5.8K Cr ▼12.1% | ₹6.6K Cr ▼5.0% | ₹6.9K Cr ▼0.4% | ₹7.0K Cr ▲13.7% | ₹6.1K Cr ▼21.5% | ₹7.8K Cr ▲18.6% | ₹6.6K Cr ▼18.2% | ₹8.0K Cr |
| Assets | ||||||||||
| Fixed Assets | ₹2.4K Cr ▲25.7% | ₹1.9K Cr ▲1.8% | ₹1.9K Cr ▼19.3% | ₹2.3K Cr ▼1.5% | ₹2.3K Cr ▲5.8% | ₹2.2K Cr ▲5.7% | ₹2.1K Cr ▼42.5% | ₹3.6K Cr ▲22.5% | ₹3.0K Cr ▼0.1% | ₹3.0K Cr |
| CWIP | ₹161 Cr ▼22.2% | ₹207 Cr ▲27.8% | ₹162 Cr ▲7.3% | ₹151 Cr ▼48.1% | ₹291 Cr ▼34.9% | ₹447 Cr ▲8.2% | ₹413 Cr ▼8.8% | ₹453 Cr ▼26.9% | ₹620 Cr ▼20.5% | ₹780 Cr |
| Investments | ₹291 Cr ▼28.9% | ₹409 Cr ▲35.0% | ₹303 Cr ▼38.2% | ₹490 Cr ▼9.3% | ₹540 Cr ▼22.5% | ₹697 Cr ▲27.0% | ₹549 Cr ▼21.8% | ₹702 Cr ▲19.4% | ₹588 Cr ▼61.4% | ₹1.5K Cr |
| Other Assets | ₹4.1K Cr ▲19.7% | ₹3.4K Cr ▼1.6% | ₹3.5K Cr ▼4.7% | ₹3.6K Cr ▼3.2% | ₹3.8K Cr ▲4.4% | ₹3.6K Cr ▲17.4% | ₹3.1K Cr ▲2.2% | ₹3.0K Cr ▲25.2% | ₹2.4K Cr ▼13.1% | ₹2.8K Cr |
| Total Assets | ₹6.9K Cr ▲16.8% | ₹5.9K Cr ▲2.2% | ₹5.8K Cr ▼12.1% | ₹6.6K Cr ▼5.0% | ₹6.9K Cr ▼0.4% | ₹7.0K Cr ▲13.7% | ₹6.1K Cr ▼21.5% | ₹7.8K Cr ▲18.6% | ₹6.6K Cr ▼18.2% | ₹8.0K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹703 Cr ▲2.8% | ₹684 Cr ▼2.4% | ₹701 Cr ▲1493.2% | ₹44 Cr ▲117.1% | ₹-258 Cr ▼153.6% | ₹481 Cr ▲134.6% | ₹205 Cr ▲241.7% | ₹60 Cr ▼67.9% | ₹187 Cr ▼35.1% | ₹288 Cr |
| Investing CF | ₹-173 Cr ▼92.2% | ₹-90 Cr ▲40.0% | ₹-150 Cr ▼149.7% | ₹302 Cr ▲353.8% | ₹-119 Cr ▲77.2% | ₹-522 Cr ▼139.5% | ₹1.3K Cr ▲1011.0% | ₹-145 Cr ▼125.4% | ₹570 Cr ▲146.6% | ₹-1.2K Cr |
| Financing CF | ₹-453 Cr ▲29.5% | ₹-643 Cr ▲7.2% | ₹-693 Cr ▼223.8% | ₹-214 Cr ▼150.8% | ₹421 Cr ▲2731.3% | ₹-16 Cr ▲99.1% | ₹-1.7K Cr ▼980.9% | ₹194 Cr ▲119.1% | ₹-1.0K Cr ▼400.6% | ₹338 Cr |
| Net Cash Flow | ₹76 Cr ▲258.3% | ₹-48 Cr ▲66.2% | ₹-142 Cr ▼206.8% | ₹133 Cr ▲195.6% | ₹45 Cr ▲180.4% | ₹-56 Cr ▲69.6% | ₹-184 Cr ▼267.3% | ₹110 Cr ▲142.5% | ₹-259 Cr ▲56.5% | ₹-596 Cr |
| Free Cash Flow | ₹291 Cr ▼42.9% | ₹510 Cr ▼24.1% | ₹672 Cr ▲1662.8% | ₹-43 Cr ▲86.8% | ₹-326 Cr ▼273.4% | ₹188 Cr ▲224.1% | ₹58 Cr ▲122.7% | ₹-256 Cr ▼20.8% | ₹-212 Cr ▲45.1% | ₹-386 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 97d ▲1.0% | 96d ▼10.3% | 107d ▼17.1% | 129d ▼10.4% | 144d ▲18.0% | 122d ▼1.6% | 124d ▼24.8% | 165d ▲46.0% | 113d ▼14.4% | 132d |
| Inventory Days | 305d ▲29.2% | 236d ▲0.4% | 235d ▼8.6% | 257d ▼9.8% | 285d ▼13.4% | 329d ▲29.5% | 254d ▼13.6% | 294d ▲101.4% | 146d ▼30.1% | 209d |
| Days Payable | 244d ▲28.4% | 190d ▲6.7% | 178d ▼19.1% | 220d ▼15.4% | 260d ▼19.5% | 323d ▲24.7% | 259d ▼13.4% | 299d ▲59.0% | 188d ▼14.9% | 221d |
| Cash Conv. Cycle | 157d ▲11.3% | 141d ▼14.0% | 164d ▼0.6% | 165d ▼1.8% | 168d ▲31.3% | 128d ▲7.6% | 119d ▼25.6% | 160d ▲125.4% | 71d ▼40.8% | 120d |
| Working Capital Days | 38d ▲58.3% | 24d ▲226.3% | -19d ▼72.7% | -11d ▲60.7% | -28d ▼27.3% | -22d ▲68.6% | -70d ▲0.0% | -70d ▼1650.0% | -4d ▲96.7% | -122d |
| ROCE | 19.0% ▲26.7% | 15.0% ▲114.3% | 7.0% | 0.0% ▲100.0% | -5.0% ▼162.5% | 8.0% ▲60.0% | 5.0% ▲150.0% | 2.0% ▼87.5% | 16.0% ▲45.5% | 11.0% |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Strides Pharma Science Limited share price today?▾
Strides Pharma Science Limited (STAR) is currently trading at ₹1,051.3 on NSE, down 0.77% as of the last market session. Prices update daily after market close on MarketNetra.
Is Strides Pharma Science Limited available in F&O (Futures & Options)?▾
Yes, Strides Pharma Science Limited (STAR) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Strides Pharma Science Limited 52-week high and low?▾
Strides Pharma Science Limited's 52-week high is ₹1,231 and the 52-week low is ₹769. The current price of ₹1,051.3 is 14.6% below the 52W high.
What is Strides Pharma Science Limited P/E ratio?▾
Strides Pharma Science Limited's current P/E ratio is 17.1. This indicates the market is paying ₹17.1 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Strides Pharma Science Limited options?▾
Strides Pharma Science Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade STAR options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.